Raymond James Maintains Outperform on CareTrust REIT, Lowers Price Target to $42
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice Target
Raymond James analyst David Rodgers maintains CareTrust REIT (NYSE:CTRE) with a Outperform and lowers the price target from $45 to $42.
Raymond James analyst David Rodgers maintains CareTrust REIT (NYSE:CTRE) with a Outperform and lowers the price target from $45 to $42.